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Objectives: Balloon angioplasty (BA) is an important treatment option for coarctation
of the aorta. The congenital cardiovascular interventional study consortium (CCISC)
represents a multi-institutional and multi-national effort to prospectively investigate
congenital cardiac interventions. A prospective observational analysis of the efficacy
and safety of balloon aortic angioplasty was conducted. Methods: Data were collected
prospectively from 36 CCISC sites from 2004 to 2012. One hundred and thirty patients
underwent BA for native (n5 76) and recurrent (n5 54) coarctation. Acute, short-term,
and intermediate outcomes are described for BA performed in the setting of native
and recurrent coarctation of the aorta. Outcome measures included residual upper to
lower extremity blood pressure gradient (ULG), use of antihypertensive medications,
aortic wall injury, reobstruction, and need for reintervention. Results: There was no
procedural mortality. Acutely in native and recurrent coarctation, BA achieved an ULG
less than 15 mm Hg in 73–80% and to less than 10 mm Hg in 54–68% of patients,
respectively. At intermediate follow-up, ULG further improved, particularly for those
who underwent initial reintervention for recurrent coarctation. No significant
differences in aortic wall complications were seen and intervention free survival was
similar for both groups. Following angioplasty, there was no significant difference in
aortic wall complications; however follow up integrated imaging decreased over time.
Conclusions: BA is a safe and effective treatment for coarctation of the aorta acutely
and at intermediate term. Although aortic injury occurred in patients with both native
and recurrent coarctation, at intermediate follow-up, aneurysm was noted more often
in those with initial intervention for native coarctation. VC 2013 Wiley Periodicals, Inc.
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INTRODUCTION
Coarctation of the aorta may be found as an isolated
lesion or may be associated with other congenital heart
abnormalities. The incidence of coarctation of the aorta
is approximately 1/3000 to 1/4000 [1]. The most com-
mon defect associated with coarctation of the aorta is a
bicuspid aortic valve, though this may not necessarily
cause hemodynamically significant valvular stenosis.
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Unrepaired coarctation of the aorta is associated with
significant morbidity and mortality, with approximately
90% mortality observed by age 50 [2]. The aorta in
patients with coarctation of the aorta is abnormal due
to histologic differences in the smooth muscle and
extracellular matrix, which may affect local compli-
ance and distensibility [3,4]. These differences may
affect the tissue response to catheter-based interven-
tions and long-term outcomes including risk for sys-
temic hypertension and aneurysm formation.
Current therapeutic options include surgery, intravas-
cular stent placement, and balloon angioplasty (BA).
Catheter-based therapies have demonstrated compara-
ble efficacy to surgery in children greater than 1 year
of age [5,6]. Outside of rescue situations or if surgical
options are limited, balloon aortic angioplasty has been
less embraced for neonates and young infants due to
concern for the high incidence of recurrent stenosis
[7]. With all forms of therapy, repeat intervention may
be required due to restenosis or aneurysm formation,
which typically occurs at the coarctation site or adja-
cent areas. There are varying reports regarding the rel-
ative complication rates of surgery compared to BA
[5,8]. BA may be complicated by aneurysm formation;
however the true risk of aneurysm formation is
unknown with estimates ranging from 8 to 35% [8–
10]. Most studies are retrospective, single institution
studies with relatively few patients, which may contrib-
ute to the divergent results. Furthermore, the historical
measure of procedural success (residual upper to lower
extremity blood pressure gradient (ULG) 20 mm Hg)
is largely an arbitrary convention [11,12]. Given that
continuing morbidities such as systemic hypertension
can affect patients after repair/intervention with mini-
mal residual blood pressure gradient [13–15], it is con-
ceivable that the standard for immediate procedural
success should be referenced to a lower gradient post-
procedure.
To better understand the efficacy and safety of BA
for the treatment of native and recurrent coarctation of
the aorta, we performed a prospective multicenter eval-
uation of the acute to intermediate-term results.
METHODS
Study Population and Design
This prospective multi-institutional observational
study involved 36 centers in the congenital cardiovas-
cular interventional study consortium (CCISC). A com-
plete list of participating centers may be found in the
online appendix. Inclusion and exclusion criteria are
listed in Table I. Institutional review board approvals
were locally obtained by each participating center.
Patients were defined as having native coarctation if
they did not have any previous surgical or catheter-
based intervention. Recurrent coarctation was defined
as coarctation occurring after previous surgery or BA
at study entry. Case report form completion for the ini-
tial angioplasty, reintervention, short term (3–18
months), and intermediate follow up (18–60 months)
was supervised by the participating physician and
entered into a secure CCISC database. Integrated imag-
ing including computed tomography (CT), magnetic
resonance imaging (MRI), or cardiac catheterization
was performed at each of the follow up intervals. Ini-
tial, follow up and reintervention imaging studies were
reviewed by core laboratory physicians. These data are
a focused and expanded extension of that reported by
Forbes et al. [6], comparing surgery, stent therapy, and
BA in the treatment of native coarctation of the aorta.
The decision to pursue BA instead of alternate therapy
was left to the discretion of the individual physicians.
Data Collection
Preintervention data. Patient demographics
including age, weight, gender, and associated diagnoses
were documented. Baseline clinical information includ-
ing upper and lower extremity systolic and diastolic
blood pressure (BP), antihypertensive medications, pre-
intervention measurements of the long axis of the aorta
(CT, MRI, or catheterization), and coarctation type/
location were documented.
Procedural data. Preprocedural gradient was
measured by direct catheter pullback from the ascend-
ing to descending aorta. A distal transverse aortic arch
BP measurement was recorded to assess potential
transverse aortic arch obstruction. Biplane angiography
was performed in the anteroposterior or left anterior
oblique and lateral views. Dimensions of the transverse
aorta, coarctation segment, area distal to the coarcta-
tion, and abdominal aorta at the level of the diaphragm
TABLE I. Inclusion and Exclusion Criteria
Inclusion criteria
1. Weight 10 kg
2. Presence of significant coarctation based on one of the following:
a. ULG >20 mm Hg
b. ULG 10 mm Hg with either decreased LV function (EF
<30%) or moderate to severe aortic insufficiency
c. ULG 10 mm Hg plus significant collateral flow supplying the
area distal to the coarctation
Exclusion criteria
1. Weight< 10 kg
2. Refusal to sign consent
3. Known or suspected arteritis
4. Requires other surgical procedure that would permit surgical
correction of the coarctation segment at the same time
kg, kilogram; ULG, upper to lower extremity systolic blood pressure
gradient; LV, left ventricle; EF, ejection fraction.
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were obtained. The balloon type, size, and length were
documented. Postprocedural gradient and angiographic
measurements were repeated in a similar fashion.
Discharge data. Upper and lower extremity BP,
complications before discharge, length of hospital stay,
and antihypertensive medication use were documented.
The decision to initiate or continue antihypertensive
therapy was at the discretion of institutional prefer-
ence.
Follow-up data. Imaging studies (MRI, CT, or an-
giography) were performed at short and intermediate-
term follow-up as described above. Patient demo-
graphics, upper and lower extremity BP, and antihyper-
tensive medications were recorded at the time of
follow-up evaluation.
Reintervention data. Reintervention was per-
formed for recurrent stenosis, as part of a staged dila-
tion strategy, and due to the development of aneurysm
formation. Hemodynamic and angiographic data were
collected in the same fashion as that at the time of the
original BA.
Definition of Coarctation/Transverse Aortic Arch
Anatomy
Proximal coarctation was defined as a coarctation
segment located 10 mm from the origin of the left
subclavian artery, with distal coarctation defined as a
coarctation segment located >10 mm from the origin
of the left subclavian artery. Hypoplastic transverse
aortic arch (TAA) was defined as a ratio of the TAA
to descending aorta measured at the level of the dia-
phragm <0.6. Aneurysm was defined as a diameter
>20% than the adjacent descending aorta (DAo) that is
not considered to be poststenotic dilation of the aorta,
or an abnormal localized enlargement of the aortic seg-
ment in the area of intervention.
Outcome Assessments
Hemodynamic outcome. Systolic BP gradient
measured from upper to lower extremities (ULG) at
the time of discharge, follow-up, and reintervention
were used as the primary hemodynamic outcomes.
These outcomes were dichotomized using 10 and 15
mm Hg ULG as cut-offs. The systolic gradient meas-
ured at coarctation site directly by catheter (ascending
to descending aorta) pre- and postintervention was
recorded.
Angiographic outcome. The coarctation repair site
dimension was compared to the aortic diameter at the
level of the diaphragm (Coarctation: DAo). Follow-up
outcomes were assessed by MRI, CT, or angiographic
measurements of the coarctation repair site.
Safety Endpoint
Safety endpoints were death, aortic wall injury, other
procedural complications, and unanticipated reinterven-
tion acutely, at short-term, and at intermediate follow-up.
Reobstruction
Reobstruction of the coarctation angioplasty site by
imaging was categorized as mild (<10% narrowing of
vessel lumen), moderate (11–30% narrowing), or
severe (>30% narrowing). However, the decision for
reintervention was not strictly dependent on the grad-
ing of reobstruction by non-invasive imaging studies.
The indication for and decision to pursue reintervention
was not predefined by the CCISC. This decision was
based on the comprehensive assessment of the individ-
ual operator with residual hemodynamic gradient taken
into consideration.
Postinterventional Hypertension
Postinterventional hypertension was defined as a per-
sistent systolic BP 95th percentile for height and
weight lasting >48 hr after the initial intervention.
Core Laboratory Assessment
All imaging data were reviewed at one of four core
laboratory centers: Nationwide Children’s Hospital,
Columbus, Ohio; National Children’s Medical Center,
Washington, D.C.; University of Texas Southwestern
Medical Center, Dallas, Texas; and Penn State Univer-
sity, Hershey, Pennsylvania.
Statistical Methods
To compare patient baseline and outcome characteris-
tics among patient groups, student’s t-test and chi-
square tests (or Fisher’s exact) were used. Kaplan-Meier
product limit actuarial curves and log-rank tests were
used to compare reintervention-free survival duration
from the time of the first procedure. Subgroup analysis
comparing children 12 years in the entire cohort with
those >12 years were performed to assess the effect of
age on patient outcomes. Furthermore, we compared
outcomes in children 7 years with native coarctation
to those <7 years with native coarctation to determine
the safety and efficacy of this procedure in younger
children. A P-value< 0.05 was considered statistically
significant, and SAS 9.3 was used for all analyses.
RESULTS
Between February 1, 2002, and October 31, 2012,
130 children from 36 institutions underwent BA for
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coarctation of the aorta. Of those, 76 underwent BA
for native coarctation and 54 for recurrent coarctation.
Baseline Characteristics
As expected, children undergoing BA for recurrent
coarctation were older (P< 0.001) and weighed more
than children with native coarctation (P< 0.001; Table
II). The preprocedure ULG was higher in children with
native coarctation. Native coarctation was almost
always located in the isthmic area past the takeoff of
the left subclavian artery, whereas, recurrent coarcta-
tion was located in the transverse arch in 15% of cases.
Recurrent coarctation in the transverse arch also was
seen in children undergoing primary surgical repair. In
those with recurrent coarctation, the primary therapy
was angioplasty in 26% (n¼ 14) and surgery in 74%
(n¼ 40). As expected, native and recurrent coarctation
were both associated with a bicuspid aortic valve in
approximately half of the cases.
Acute Outcomes
Hemodynamic outcomes were assessed by measuring
the preintervention and discharge ULG noninvasively.
In both groups, angioplasty significantly reduced the
ULG from preintervention to time of discharge (Table
III). The discharge ULG was lower in children with
recurrent coarctation. Notably, approximately 3/4 of
patients in both groups had an ULG 15 mm Hg after
angioplasty. The majority of patients in both groups
(54% native, 68% recurrent) also met the criteria for
ULG 10 mm Hg at the time of discharge.
There were no deaths in either group. The rate of
aortic wall injury was low (11% native, 7% recurrent)
predominantly due to intimal tear or dissection. There
was one aneurysm noted acutely (<1%) in a patient
undergoing BA for recurrent coarctation. There was
one balloon rupture without significant sequelae in
each group and one femoral hematoma in the recurrent
coarctation group. The length of hospital stay post-BA
was similar for native and recurrent coarctation.
Short-Term Outcomes
Short-term follow-up was available for 45 patients
with native coarctation and 30 patients with recurrent
coarctation, representing 59 and 56% of the initial
cohorts, respectively. At short-term follow-up, approxi-
mately 3/4 of patients has normal systolic blood pres-
sure (SBP) (Table IV) with antihypertensive use of
16% in the native coarctation group and 30% in the
recurrent coarctation group (this difference did not
achieve statistical significance, however). Mean ULG
remained low at less than 10 mm Hg. When compared
to acute outcomes at residual ULG cutoffs at 10 mm
Hg, patients undergoing angioplasty for both native
and recurrent coarctation maintained a similar result as
noted at the time of the procedure. Available integrated
imaging follow-up was similar for both groups (73%
native, 80% recurrent). There was a larger vessel cali-
ber at the site of coarctation for those undergoing
angioplasty due to recurrent obstruction compared to
those with native coarctation (coarctation to descending
aorta ratio of 0.75 and 0.88 in native and recurrent co-
arctation, respectively, P¼ 0.03). Reobstruction as
assessed by imaging was noted in 22% of patients with
native coarctation and was most often mild. Reobstruc-
tion was rare in patients with recurrent coarctation
(7%). Continuing aortic wall injury was noted in 27%
of imaged patients with native coarctation of the aorta
(20% patients with short-term follow-up). Aortic aneur-
ysms were noted by integrated imaging in seven
patients (21% of imaged patients, 16% with short-term
follow-up) with native coarctation and in two patients
(8% of imaged patients, 7% with short-term follow-up)
those with recurrent coarctation. There were no inter-
stage deaths.
Intermediate-Term Outcomes
Intermediate-term follow-up was available for 34
patients with native coarctation 27 patients with recur-
rent coarctation, representing 45 and 50% of the initial
cohorts, respectively. At intermediate-term follow-up,
68% of patients with native coarctation and 88% of
patients with recurrent coarctation had normal SBP
(Table V). The rate of antihypertensive therapy was
TABLE II. Baseline Characteristics
Patient characteristics
Native
n¼ 76
Recurrent
N¼ 54
P
(two-sided)
Age (years; mean6 SD) 8.06 7.5 13.86 10.3 <0.001
Weight (kg; mean6 SD) 26.96 19.4 44.96 22.5 <0.001
Male (vs. Female %) 48 (63%) 33 (61%) 0.85
Preprocedure right-arm
systolic blood pressure
(mm Hg; mean6 SD)
1356 23 1286 17 0.04
Preprocedure ULG
(mean6SD)
416 3 216 18 <0.001
Coarctation Location (%)
Isthmus 95% 77%
Distal 66% 32%
Proximal 28% 45%
Transverse aorta 3% 15%
Abdominal/thoracic aorta 1% 0%
Complex 1% 8%
Single ventricle 0% 6% 0.07
Shone syndrome 0% 6% 0.07
Bicuspid aortic valve (%) 47% 44% 0.86
SD, standard deviation; ULG, upper to lower extremity systolic blood
pressure gradient.
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slightly lower than at short-term follow-up with only
12% use in the native coarctation group and 30% use
in the recurrent coarctation group, suggesting an ability
to wean from antihypertensive medications for many.
The ULG remained lower in those with recurrent co-
arctation compared to native coarctation, as was seen
acutely and at short-term follow-up, suggestive of
ongoing vascular remodeling. The ULG was 15 mm
Hg in 94% of those with recurrent coarctation and
73% of those with native coarctation. ULG was 10
mm Hg in 94% treated for recurrent coarctation and
60% for those with native coarctation. Integrated imag-
ing was available for 62% of native and 67% of recur-
rent patients. Imaging outcomes demonstrated a similar
coarctation to descending aorta ratio in both native and
recurrent coarctation (0.77 and 0.78). At intermediate-
term follow-up, reobstruction as assessed by integrated
imaging was seen in 24% of patients (15% of all with
intermediate follow-up) with native coarctation and 22%
of patients (15% of all with intermediate follow-up) in
the recurrent coarctation group. Reobstruction was
described as mild in all patients in the native coarctation
group. Two of four patients in the recurrent group had
reobstruction described as severe. There were two aortic
aneurysms seen in the recurrent coarctation group (11%
with imaging, 7% of all with intermediate follow up)
and eight aneurysms in patients with native coarctation
at intermediate-term follow-up (38% with imaging, 24%
of all with intermediate follow-up).
Time to Reintervention
Thirteen patients underwent reintervention (eight native
coarctation and five recurrent coarctation). The need for
reintervention was determined by the interventional cardi-
ologist performing the procedure without predetermined
criteria established by the CCISC. The most common in-
dication for reintervention was moderate to severe reob-
struction (12/13). There was one case of reintervention
due to aortic wall injury initially detected at short-term
follow-up, which occurred after BA for native coarctation.
The overall reintervention free survival probability was
approximately 95% at 1 year and 85% at 10 years. There
was no significant difference in reintervention rates
between native and recurrent coarctation (Fig. 1).
TABLE III. Acute Outcomes
Patient characteristics
Native
n¼ 76
Recurrent
N¼ 54
P
(two-sided)
Discharge ULG (Mean6SD) 96 14 36 16 0.02
Discharge ULG 10 mm Hg (%) 54% 68% 0.19
Discharge ULG 15 mm Hg (%) 73% 80% 0.40
Any complications (#, %) 9 (12%) 7 (13%) 0.81
Aortic wall complications (#, %) 8 (11%) 5 (7%) 0.55
Aneurysm (#) 0 1
Dissection (#) 3 2
Intimal tear (#) 5 2
Balloon rupture (#) 1 1
Femoral hematoma (#) 0 1
Length of stay in days
(mean6SD)
2.96 9.0 1.76 4.3 0.32
ULG, upper to lower extremity systolic blood pressure gradient; SD,
standard deviation.
TABLE IV. Short-Term Follow-Up
Clinical follow-up outcomes
Native
n¼ 45
Recurrent
N¼ 30 P (two-sided)
Normal systolic blood pressure 78% 72% 0.60
Antihypertensive medication 16% 30% 0.14
ULG (Mean6 SD) 86 18 06 22 0.11
ULG 10 mm Hg 43% 67% 0.05
ULG 15 mm Hg 68% 74% 0.56
Integrated imaging
follow-up outcomes
n¼ 33 n¼ 24
Any complications
(#, % imaged subgroup)
16 (48%) 5 (21%) 0.03
Aortic wall injury
(#, % imaged subgroup)
9 (27%) 2 (8%) 0.07
Dissection/intimal tear (#) 2 0
Aneurysm (#) 7 2
Coarctation: Descending Aortic
ratio (mean6 SD)
0.756 0.22 0.886 0.21 0.03
Any reobstruction (#) 11 3 0.20
Mild (#) 6 2
Moderate (#) 1 1
Severe (#) 4 0
ULG, upper to lower extremity systolic blood pressure gradient; SD,
standard deviation.
TABLE V. Intermediate-Term Follow-Up
Clinical follow-up outcomes
Native
n¼ 34
Recurrent
N¼ 27
P
(two-sided)
Normal systolic blood pressure 68% 88% 0.06
Antihypertensive medication 12% 30% 0.08
ULG (mean6SD) 46 17 136 18 <0.01
ULG 10 mm Hg 60% 94% 0.04
ULG 15 mm Hg 73% 94% 0.12
Integrated imaging follow-up
outcomes
n¼ 21 n¼ 18
Any complications
(#, % imaged subgroup)
12 (57%) 6 (33%) 0.20
Aortic wall injury
(#, % imaged subgroup)
9 (43%) 3 (17%) 0.17
Dissection/intimal tear (#) 1 1
Aneurysm (#) 8 2
Coarctation: Descending Aortic
ratio (mean6 SD)
0.776 0.12 0.786 0.18 0.92
Any reobstruction (#) 5 4 0.13
Mild (#) 5 1
Moderate (#) 0 1
Severe (#) 0 2
ULG, upper to lower extremity systolic blood pressure gradient; SD,
standard deviation.
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Subgroup Analysis by Age
Subgroup analysis was performed to assess the effect
of age on the results. Because entry into the teenage/ad-
olescent years represents a time period where coarcta-
tion stenting has generally been considered acceptable,
we assessed those 12 years in the overall population
compared to those >12 years. As BA may be favored in
younger children over primary stenting, we also
assessed the safety and efficacy of BA for native coarc-
tation in children <7 years compared to those 7 years
to determine the acute efficacy, short-term and
intermediate-term follow-up, and complications. The
most striking finding from the subgroup analysis was
that children <7 years with native coarctation have sim-
ilar rates of acute complications and aortic wall injury
at short- and intermediate-term follow-up. There was a
trend toward fewer young children achieving an ULG
10 mm Hg (45% in those <7 years compared to 67%
in those 7 years). However, 73% of children <7 years
had an ULG 15 mm Hg acutely, which was identical
to the rate seen in children 7 years. In the overall
cohort there were no significant differences in measures
of success or complication rates between those >12
years and those 12 years. No other statistically signifi-
cant differences were noted.
DISCUSSION
Native and recurrent aortic coarctations are both
amenable to catheter-based intervention. Our results
confirm that native and recurrent coarctation respond
differently to BA. The reduction in the coarctation gra-
dient was greater for patients with recurrent coarctation
both acutely and through intermediate-term follow-up
based on non-invasive BP measurements. In the recur-
rent coarctation group at intermediate-term follow-up,
87% had an ULG< 10 mm Hg and 94% <15 mm Hg
indicating that the effectiveness of this therapy is sus-
tained over time. Our results compare favorably with
previously published data [16,17], although, notably
our definition of recurrent coarctation included patients
who had previous surgical repair or BA before study
enrollment. The historically accepted definition of suc-
cess after BA has been a final gradient <20 mm Hg.
As catheter-based therapies and surgical techniques
have matured, this definition of success may require
re-evaluation. We present data at cut points of 15 mm
Hg and 10 mm Hg BP gradients. Importantly, a trend
of decreasing ULG over time was observed during
follow-up suggestive of ongoing remodeling in the
aorta following BA.
Native coarctation may be successfully treated with
BA; however, these data show that it is more frequently
associated with reobstruction, which is most often mild.
The recent report from the CCISC demonstrated supe-
rior hemodynamic results with stent placement and sur-
gery compared to BA [6]. Furthermore, there was a
lower complication rate with stent placement compared
to BA alone. As such, the current trend seems to be
shifting toward primary stent placement in older chil-
dren and adults while surgery remains favored in young
children [18,19]. BA as a bridge to stent therapy may
be an effective alternative to surgery for young children
who are too small to initially accommodate a stent that
can be serially dilated to adult size. The comparable
safety of BA in children less than 7 years old in our
study population would support this approach.
Persistent hypertension is known to be a continuing
morbidity following treatment of coarctation in up to
half of patients [20]. In our cohort, the use of antihy-
pertensive therapy declined from short-term to
intermediate-term follow-up in children with native co-
arctation (16–12%). This is consistent with the
expected resolution of hypertension over time after
improvement in aortic obstruction. Some patients will
have hypertension that persists and may contribute to
long-term morbidity [20,21]. Notably, the overall use
of antihypertensive therapy at intermediate follow-up
was lower in children under 12 years of age (3%) than
those over 12 years (30%). Although this may be in
part due to age related differences in the tissue recov-
ery and remodeling process, we hypothesize there may
be a bias toward withholding antihypertensive medica-
tions in young children compared to older children. In
addition, under recognition of hypertension in patients
after treatment for coarctation of the aorta may par-
tially explain this observation [22].
Complications seen in the setting of BA may include
aortic wall injury characterized by intimal tear, vascu-
lar dissection, aneurysm formation, femoral hematoma
Fig. 1. Intervention-free survival in native and recurrent co-
arctation. [Color figure can be viewed in the online issue,
which is available at wileyonlinelibrary.com.]
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at the entry site, and neurologic complications. There
were no neurologic complications in either group. There
was one femoral hematoma (<1%). The rate of angio-
graphically identifiable acute aortic wall injury was sim-
ilar in both groups at approximately 10%. The rate of
aneurysm formation increased over time. At intermedi-
ate follow-up there was a higher rate of aortic wall
irregularity in the native coarctation group although this
difference was not statistically significant. The overall
aneurysm rate at intermediate follow-up was 26% with
eight of ten aneurysms seen in the native coarctation
group. Spontaneous improvement in aneurysm size was
seen over time in two patients undergoing BA for recur-
rent coarctation, whereas three new aneurysms were
noted in patients with native coarctation. Given these
low numbers, we can only speculate whether this is re-
flective of how mechanical manipulation by BA affects
the substrate involving recurrent coarctation compared
to native coarctation. The progression of aortic wall
injury over time requires further investigation given its
important implications in determining how to manage
these complications. The rate of aneurysm formation
seen in this study is similar to previous reports where
aneurysms were seen in up to 35% of patients [8]. In
studies limited to older adolescents and adults, the rate
of aneurysm formation is considerably lower [23,24].
However, there may be a bias in obtaining integrated
imaging follow-up after angioplasty for aortic coarcta-
tion, with less additional imaging occurring in patients
for whom there is less clinical concern for aneurysm
formation. Follow-up integrated imaging at
intermediate-term was suboptimal with 39 of the origi-
nal 130 patients continuing to receive additional imag-
ing. There was notable attrition from intake through to
intermediate follow-up with fewer children undergoing
integrated imaging than clinical follow-up. Some attri-
tion was due to the time interval between the interven-
tion and the specified follow-up, as some of the children
who have undergone intervention have not yet reached
the specified follow-up periods. In addition, there was
some loss to follow-up and adherence to recommend
integrated imaging scheduling was incomplete. A more
complete understanding of the relationship between aor-
tic coarctation interventions and the natural history of
aortic wall injury requires more knowledge of the coarc-
tation substrate, before and after intervention. A more
detailed characterization of aortic pathology, beyond the
designation of recurrent vs. native coarctation, is likely
needed. This may be possible with more in depth
knowledge of structural vessel wall changes, vascular
properties, and cellular components in the affected area
of the aorta.
Reintervention-free survival was similar in native
and recurrent coarctation despite the finding that ULG
was different in these groups postintervention. It is
possible that the higher ULG in native coarctation may
be due to more frequent mild obstruction that does not
necessitate reintervention. Alternatively, the similar
reintervention rates despite discrepant ULG may be
due to a lack of predefined criteria for reintervention.
A third possibility is that the sample size was too small
to detect a difference in reintervention rates given the
relatively small number of patients that had extended
follow-up. Nonetheless, the overall reintervention-free
survival was >90% at 1 year and >80% at 5 and 10
years. It is important to note that while this demon-
strates excellent results in a broad population of chil-
dren and young adults with coarctation, children <10
kg were excluded in this study. As such, we have
excluded children who underwent BA for recurrent co-
arctation in the setting of a recent Norwood procedure,
which is known to have higher reintervention rates
[25].
The strengths of this study are that it includes a
large number of patients from multiple centers. The
patients were followed for up to 10 years. As with all
registries, the main limitation this consortium faced
was difficulty obtaining complete follow-up data, par-
ticularly integrated imaging. The choice of the type of
follow-up imaging was left to physician discretion and
there is some possibility that there could be some dif-
ference in dimensional measurements, although imag-
ing was reviewed at core laboratory centers. Finally,
the indications for reintervention were not predeter-
mined and there remains considerable variability in the
pattern of practice with regard to deciding when to
reintervene. We did further stratify outcomes to cut
points of 15 mm Hg and 10 mm Hg, which contin-
ued to show good hemodynamic results, particularly
for those undergoing angioplasty for recurrent coarcta-
tion.
CONCLUSIONS
In summary, BA can be an effective strategy for
treatment of coarctation of the aorta outside of infancy.
It is a safe and highly effective therapy for recurrent
coarctation of the aorta. Native coarctation treated with
BA results in reduced coarctation gradients, although
there is a trend toward recurrence of mild obstruction.
Both native and recurrent coarctations have excellent
reintervention-free survival through intermediate-term
follow-up after BA. The historic arbitrary hemody-
namic cutoff by which success following BA was
defined (20 mm Hg) may be inadequate in the cur-
rent era. At additional criteria of residual gradient 15
mm Hg and 10 mm Hg, BA continues to be an effec-
tive therapy, particularly for those treated for recurrent
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obstruction. Aneurysm formation remains a concern af-
ter any treatment for coarctation of the aorta, particu-
larly BA for native coarctation, although further
treatment of these aneurysms is rare in the intermediate
term. Further research is needed to find the optimal
balance between relief of aortic obstruction and mini-
mizing the risk of aneurysm formation to optimize
long-term health outcomes for patients with coarctation
of the aorta.
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